While rare, its possible to experience pancreatitis (inflammation of the pancreas), kidney problems (like kidney stones), acute gallbladder disease, and an increased risk of thyroid cancer
This dual action helps normalize blood glucose with lower risk of hypoglycemia compared to some older diabetes medications, though the risk increases when combined with insulin or sulfonylureas
Severe abdominal pain, particularly if accompanied by nausea, vomiting, and fever, may indicate pancreatitis, a rare but serious complication that has been reported with incretin-based therapies
Biosimilar drugmaker Biocon Biologics acquired Viatris biosimilars business for a total of US$ 3.34 billion, strengthening its presence in the diabetes, tumors and autoimmune diseases market